Public health priority |
Priority, perception, Millennium Development Goals |
Disease burden |
Burden, incidence, prevalence, hospitalization, impact, mortality, cost, deaths, epidemiology, characteristic, etiology |
Efficacy, quality and safety |
Vaccine, efficacy, quality, safety, effectiveness, adverse event, standards, clinical trial |
Other inventions |
Antiviral, non-pharmaceutical |
Economic and financial issues |
Economic, budget, finance, funding, sustainability, cost-effectiveness, affordability, fiscal impact |
Vaccine presentation |
Presentation, formulation, dose |
Supply availability |
Supply, availability, manufacture, procurement, introduction strategy |
Programmatic strength |
Delivery, National Immunization Programme |
Key issues as per the WHO Vaccine Introduction Guidelines |
Keywords used to classify studies to these issues |
Public health priority |
Priority, perception, Millennium Development Goals |
Disease burden |
Burden, incidence, prevalence, hospitalization, impact, mortality, cost, deaths, epidemiology, characteristic, etiology |
Efficacy, quality and safety |
Vaccine, efficacy, quality, safety, effectiveness, adverse event, standards, clinical trial |
Other inventions |
Antiviral, non-pharmaceutical |
Economic and financial issues |
Economic, budget, finance, funding, sustainability, cost-effectiveness, affordability, fiscal impact |
Vaccine presentation |
Presentation, formulation, dose |
Supply availability |
Supply, availability, manufacture, procurement, introduction strategy |
Programmatic strength |
Delivery, National Immunization Programme |